UnitedHealth Group (NYSE:UNH) Price Target Increased to $571.00 by Analysts at Piper Sandler

UnitedHealth Group (NYSE:UNH) had its target price raised by stock analysts at Piper Sandler from $566.00 to $571.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. Piper Sandler’s price objective would indicate a potential upside of 18.89% from the company’s previous close.

UNH has been the topic of several other research reports. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Royal Bank of Canada cut their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $571.20.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $11.39 during mid-day trading on Wednesday, reaching $480.28. 6,631,769 shares of the company were exchanged, compared to its average volume of 4,434,561. The company has a fifty day simple moving average of $490.31 and a 200-day simple moving average of $515.63. The firm has a market cap of $442.78 billion, a PE ratio of 20.17, a PEG ratio of 1.22 and a beta of 0.54. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.54 by $0.37. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.26 EPS. As a group, equities research analysts expect that UnitedHealth Group will post 27.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Toth Financial Advisory Corp boosted its stake in shares of UnitedHealth Group by 1.5% in the 1st quarter. Toth Financial Advisory Corp now owns 20,024 shares of the healthcare conglomerate’s stock worth $9,906,000 after buying an additional 302 shares during the last quarter. Trifecta Capital Advisors LLC lifted its stake in UnitedHealth Group by 4.4% in the first quarter. Trifecta Capital Advisors LLC now owns 9,942 shares of the healthcare conglomerate’s stock valued at $4,918,000 after purchasing an additional 420 shares during the last quarter. Reliant Investment Management LLC lifted its stake in UnitedHealth Group by 2.2% in the first quarter. Reliant Investment Management LLC now owns 11,533 shares of the healthcare conglomerate’s stock valued at $5,705,000 after purchasing an additional 251 shares during the last quarter. Weaver Consulting Group lifted its stake in UnitedHealth Group by 4.6% in the first quarter. Weaver Consulting Group now owns 593 shares of the healthcare conglomerate’s stock valued at $293,000 after purchasing an additional 26 shares during the last quarter. Finally, Occidental Asset Management LLC lifted its stake in UnitedHealth Group by 1.7% in the first quarter. Occidental Asset Management LLC now owns 6,293 shares of the healthcare conglomerate’s stock valued at $3,113,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.